Stocks rally again, but finish October with steep losses
Stocks climbed for the second day in a row Wednesday at the end of a brutal month for the global market.
Investing
Articles
U.S. stocks surge on solid earnings to break losing streak
The rally wiped out a large part of the market’s plunge from the day before, but stocks are still down sharply over the past three weeks.
Buckle up: Wall Street volatility is back with a vengeance
If you're an investor who was lulled to sleep by the stock market's calm, steady gains this summer, you're wide awake by now.
Think tank Sagamore Institute promotes ‘impact investing’
Commonwealth Indiana aims to create both economic and social returns for investors.
With stock market in freefall, earnings mean almost nothing
A quarter of the way through earnings season and 10 months into what is sure to be the biggest year for profit growth this decade, the numbers are strong. The market doesn’t care.
Scale Computing scores $34.8M round of funding, plans to add 100-plus employees
Scale Computing Inc. has landed one of the biggest rounds of financing in Indiana in recent years and is planning to more than double its workforce over the next two years.
NASDAQ suffers worst day since 2011 amid market rout
Major market indexes had a dismal day Wednesday, especially the tech-heavy NASDAQ.
Stocks surge, recovering much of last week’s losses
U.S. stocks rocketed to their biggest gain in six months Tuesday following strong earnings from major financial and health care companies as well as encouraging reports on the economy.
High Alpha venture studio launches worker-safety software firm
Indianapolis-based venture studio High Alpha on Tuesday announced the start of a new cloud-based software firm that plans to market business-safety applications to reduce and prevent injuries for maintenance workers.
Elanco shares lowest since IPO after failing to get consensus buy rating
Shares in Elanco Animal Health Inc. slipped as much as 3.3 percent Monday morning after lead managers and other banks involved in its recent initial public offering started coverage on the animal health company.
BioCrossroads forms $9M seed fund for life science startups
The Indiana Seed Fund III is an early-stage fund focused on developing startups in life sciences, health IT and agricultural biosciences.
U.S. stocks suffer second straight day of heavy losses
The Standard & Poor's 500 index fell more than 2 percent for a second straight day and is now in its longest slide since 2016.
Trump blames Fed for stock market rout, says he won’t fire Powell
President Donald Trump repeatedly criticized the Federal Reserve over the past 24 hours as markets plunged, saying the central bank was “going loco” with too many interest hikes.
Trump steps up Fed pressure with ‘gone crazy’ jab after market sell-off
President Donald Trump slammed the Federal Reserve as “crazy” for its interest-rate increases this year in comments hours after the worst U.S. stock market sell-off since February.
Indiana venture capital activity surges in third quarter, report says
Hoosier companies landed $53.5 million in venture capital on 16 deals from July 1 to Sept. 31, according the report released Tuesday.
California becomes first state to require women on corporate boards
The California Chamber of Commerce said the policy will be difficult for companies to implement and violates constitutional prohibitions against discrimination.
Musk ousted as Tesla chairman in SEC settlement, but will remain CEO
The settlement was reached two days after the SEC sued the billionaire over his tweeted claims to have had the funding and investor support to buy out stockholders at $420 a share.
SEC seeks to oust Tesla CEO Musk over go-private tweet
Peter Henning, a law professor and a former SEC lawyer, said it's the first fraud case involving use of social media by the CEO of a public company.
The case for (and against) investing in Elanco Animal Health
Investors hope Greenfield-based Elanco—the No. 4 animal health company in the world—will be the next Zoetis, the former animal-health division of Pfizer, which has nearly tripled in value since going public in 2013.
Notre Dame’s endowment value hits record $13.1 billion on gains
The University of Notre Dame’s endowment posted a 12.2 percent annual investment gain.